Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1155/2018/7531718 http://hdl.handle.net/11449/164123 |
Resumo: | We aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation. |
id |
UNSP_e2f8594490afd3828c079a800fec4b5e |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/164123 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell RestorationWe aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Reitoria/UNESPFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Univ Estadual Paulista, UNESP, Botucatu Med Sch FMB, Dept Trop Dis, Botucatu, SP, BrazilUNESP, FMB, Dept Pathol, Botucatu, SP, BrazilUniv Milan, Dept Biomed & Clin Sci, Milan, ItalyUniv Estadual Paulista, UNESP, Botucatu Med Sch FMB, Dept Trop Dis, Botucatu, SP, BrazilUNESP, FMB, Dept Pathol, Botucatu, SP, BrazilFAPESP: 2010/139225Hindawi LtdUniversidade Estadual Paulista (Unesp)Univ MilanTasca, Karen Ingrid [UNESP]Correa, Camila Renata [UNESP]Caleffi, Juliana Trindade [UNESP]Mendes, Monica Banwart [UNESP]Gatto, Mariana [UNESP]Manfio, Vanessa Martinez [UNESP]Camargo, Caio Cavassan de [UNESP]Tavares, Francilene Capel [UNESP]Biasin, MaraSouza, Lenice do Rosario de [UNESP]2018-11-26T17:49:12Z2018-11-26T17:49:12Z2018-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11application/pdfhttp://dx.doi.org/10.1155/2018/7531718Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018.2314-8861http://hdl.handle.net/11449/16412310.1155/2018/7531718WOS:000430602000001WOS000430602000001.pdf50205598265681820000-0003-1948-5071Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal Of Immunology Research1,352info:eu-repo/semantics/openAccess2024-09-03T13:14:42Zoai:repositorio.unesp.br:11449/164123Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:14:42Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
title |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
spellingShingle |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration Tasca, Karen Ingrid [UNESP] |
title_short |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
title_full |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
title_fullStr |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
title_full_unstemmed |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
title_sort |
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4(+) T Cell Restoration |
author |
Tasca, Karen Ingrid [UNESP] |
author_facet |
Tasca, Karen Ingrid [UNESP] Correa, Camila Renata [UNESP] Caleffi, Juliana Trindade [UNESP] Mendes, Monica Banwart [UNESP] Gatto, Mariana [UNESP] Manfio, Vanessa Martinez [UNESP] Camargo, Caio Cavassan de [UNESP] Tavares, Francilene Capel [UNESP] Biasin, Mara Souza, Lenice do Rosario de [UNESP] |
author_role |
author |
author2 |
Correa, Camila Renata [UNESP] Caleffi, Juliana Trindade [UNESP] Mendes, Monica Banwart [UNESP] Gatto, Mariana [UNESP] Manfio, Vanessa Martinez [UNESP] Camargo, Caio Cavassan de [UNESP] Tavares, Francilene Capel [UNESP] Biasin, Mara Souza, Lenice do Rosario de [UNESP] |
author2_role |
author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Univ Milan |
dc.contributor.author.fl_str_mv |
Tasca, Karen Ingrid [UNESP] Correa, Camila Renata [UNESP] Caleffi, Juliana Trindade [UNESP] Mendes, Monica Banwart [UNESP] Gatto, Mariana [UNESP] Manfio, Vanessa Martinez [UNESP] Camargo, Caio Cavassan de [UNESP] Tavares, Francilene Capel [UNESP] Biasin, Mara Souza, Lenice do Rosario de [UNESP] |
description |
We aimed to analyze markers of immune activation, inflammation, and oxidative stress in 92 asymptomatic HIV-infected patients according to the adequate (AR, >500 cells/mm(3)) or inadequate (IR, <500 cells/mm(3)) CD4(+) T recovery and the presence or absence of antiretroviral treatment (cART). In relation to those newly diagnosed, they were divided into two groups, cART-naive IR (nIR) and cART-naive AR (nAR). Among those diagnosed more than five years ago, the following division was made: the cART-naive long-term nonprogressors (LTNP); patient under cART and AR (tAR); and patients under cART and IR (tIR). We investigated the expression of soluble receptor for advanced glycation end products (sRAGE), high-mobility group-box protein -1 (HMGB1), soluble CD14 (sCD14), IL-8, IL-10, 8-isoprostane, vitamins, and DNA damage. We observed higher levels of sRAGE in tAR as compared to nIR, nAR, LTNP, and more sCD14 than in nIR and nAR. As for IL-10 levels, we found nIR > nAR > LTNP > tAR > tIR. Higher levels of 8-isoprostane were observed in nIR. LTNP presented a higher retinol dosage than tAR and less genotoxic damage induced by oxidative stress than the other groups. We suggest that the therapy, despite being related to lesser immune activation and inflammation, alters the vitamin profile and consequently increases the oxidative stress of patients. In addition, the lowest genotoxic index for LTNP indicates that both VL and cART could be responsible for the increased DNA damage. More studies are needed to understand the influence of cART on persistent immune activation and inflammation. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-11-26T17:49:12Z 2018-11-26T17:49:12Z 2018-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1155/2018/7531718 Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018. 2314-8861 http://hdl.handle.net/11449/164123 10.1155/2018/7531718 WOS:000430602000001 WOS000430602000001.pdf 5020559826568182 0000-0003-1948-5071 |
url |
http://dx.doi.org/10.1155/2018/7531718 http://hdl.handle.net/11449/164123 |
identifier_str_mv |
Journal Of Immunology Research. London: Hindawi Ltd, 11 p., 2018. 2314-8861 10.1155/2018/7531718 WOS:000430602000001 WOS000430602000001.pdf 5020559826568182 0000-0003-1948-5071 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal Of Immunology Research 1,352 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
11 application/pdf |
dc.publisher.none.fl_str_mv |
Hindawi Ltd |
publisher.none.fl_str_mv |
Hindawi Ltd |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1810021372848504832 |